Posted in:News Hospira Files Three IPR Petitions on Herceptin® Patents By C. Nichole Gifford January 21, 2017 Hospira, Inc. (“Hospira”) filed three petitions with the Patent Trial and Appeal Board (“PTAB”) on January 20, 2017 for inter... Read more Tagged with: Genentech, Herceptin®, Hospira, IPR, Legal, News, Pfizer, PTAB, Roche, trastuzumab, USPTO